Article
TP53 rs28934571 polymorphism increases the prognostic risk in hepatocellular carcinoma.
Biomarkers in medicine - 1 Jun 2021
Zhao Yichao, Zhu Chaoqian, Chang Qing, Yang Jie, Liu Yuanguang, Peng Peng, Liu Chunmei, Cheng Ran, Chen Xiaonan, Wu Yijie, Cheng Ling, Hu Liang, Wu Xiaotang, Yin Jun
Abstract excerpt
Aim: Hepatocellular carcinoma (HCC) is considered to be the third leading cause of cancer death. The homologous gene of TP53 is significant in the occurrence and development of cancer. This study explored the relationship between TP53 rs28934571 polymorphism and HCC risk in Guangxi, China. Materials & methods: We first screened the association through bioinformatics. Additionally, a case-control study was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
